CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-06 | ANSARI ABID Chief Financial Officer | Exercise or conversion | +17,566 | $1.20 | $21K | 121,211 |
| 2020-01-06 | ANSARI ABID Chief Financial Officer | Exercise or conversion | +2,634 | $1.18 | $3K | 123,845 |
| 2020-01-06 | ANSARI ABID Chief Financial Officer | Exercise or conversion · Employee Stock Options (Right to Buy) | −17,566 | 26,351 | ||
| 2020-01-06 | ANSARI ABID Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,634 | 4,392 | ||
| 2019-12-19 | Heery Christopher Chief Medical Officer | Purchase | +250 | $12.09 | $3K | 250 |
| 2019-12-19 | Heery Christopher Chief Medical Officer | Purchase | +2,235 | $12.08 | $27K | 2,485 |
| 2019-11-08 | Buehler Kevin Director | Grant or award · Stock Option (Right to Buy) | +60,776 | 60,776 | ||
| 2019-09-23 | KHAZI FAYAZ CEO of Elo Life Systems | Grant or award · Employee Stock Option (Right to Buy) | +28,833 | 28,833 | ||
| 2019-09-23 | JANTZ DEREK Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +52,651 | 52,651 | ||
| 2019-09-23 | THOMSON DAVID S. Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,922 | 30,922 | ||
| 2019-09-23 | ANSARI ABID Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +52,818 | 52,818 | ||
| 2019-09-23 | KANE MATTHEW R. President and CEO | Exercise or conversion | +10,000 | $1.18 | $12K | 1,812,427 |
| 2019-09-23 | KANE MATTHEW R. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 13,422 | ||
| 2019-09-23 | KANE MATTHEW R. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +262,252 | 262,252 | ||
| 2019-09-10 | JANTZ DEREK Chief Scientific Officer | Exercise or conversion | +13,176 | $1.18 | $16K | 3,858,346 |
| 2019-09-10 | JANTZ DEREK Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −13,176 | 10,246 | ||
| 2019-07-04 | Scimeca Dario General Counsel | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2019-06-10 | ANSARI ABID Chief Financial Officer | Exercise or conversion | +96,618 | $1.20 | $116K | 96,618 |
| 2019-06-10 | ANSARI ABID Chief Financial Officer | Exercise or conversion | +7,027 | $1.18 | $8K | 103,645 |
| 2019-06-10 | ANSARI ABID Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −96,618 | 43,917 |
Page 26 of 28 · 549 trades